467 results on '"Misicka, Aleksandra"'
Search Results
52. In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity
53. Cross interaction of β-amyloid peptide and prion protein fragments
54. Constrainedδ opioid peptides: Analogs of DPDPE and deltorphin I containing trimethylphenylalanine instead of phenylalanine
55. Solid state conformation of serine3 DPDPE
56. In Vitro Biological Evaluation of Aprepitant Based 177 Lu-Radioconjugates.
57. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complex
58. Novel bifunctional hybrid compounds designed to enhance the effects of opioids and antagonize the pronociceptive effects of nonopioid peptides as potent analgesics in a rat model of neuropathic pain
59. Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
60. Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus
61. Huperzine A and Huperzine B Production by Prothallus Cultures of Huperzia selago (L.) Bernh. ex Schrank et Mart
62. Small Cyclic Peptide for Pyrophosphate Dependent Ligation in Prebiotic Environments
63. β2-Homo-Amino Acid Scan of µ-Selective Opioid Tetrapeptide TAPP
64. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine
65. SERS and DFT Study of Noble-Metal-Anchored Cys-Trp/Trp-Cys Dipeptides: Influence of Main-Chain Direction and Terminal Modifications
66. Antiproliferative effects of [D-Pro2, D-Trp7,9]-Substance P and aprepitant on several cancer cell lines and their selectivity in comparison to normal cells
67. Effect of interchain hydrogen bonding on electron transfer through alkanethiol monolayers containing amide bonds
68. P-50 - Radiolabeled peptidomimetic inhibitors of the VEGF:NRP-1 complex as diagnostic: therapeutic radiopharmaceuticals
69. P-44 - In vitro binding characteristic evaluation of radioconjugates targeting NRP-1 and: or NK1 receptor on glioma cancer model
70. Biphalin
71. Somatostatin analogues containing o-aminomethylphenylacetic acid as a bridge unit
72. Benzomorphan alkaloids: Natural peptidomimetics of opioid peptide pharmacophores
73. Staining of Some Synthetic Oligopeptides Using Ninhydrin Solution
74. Biological Consequences of the Incorporation of Amphiphilic Amino Acids into Opioid Peptide Sequences
75. Equilibrium of thecis-trans isomerisation of the peptide bond with N-alkyl amino acids measured by 2D NMR
76. Equilibrium of the Cis-Trans Isomerisation of the Peptide Bond with N-alkyl Amino Acids Measured by 2D NMR
77. Electron transfer through organic monolayer films with oligoglycine spacers
78. Spectroscopic identification of AZT derivative obtained from biotransformation of AZT by Stenotrophomonas maltophilia
79. Gαi-derived peptide binds the µ-opioid receptor
80. Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165
81. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis
82. Affinity of fentanyl and its derivatives for the σ1-receptor
83. Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method
84. The synthesis and opioid receptor binding affinities of dermorphin and deltorphin analogs with dibasic amino acids in position 2
85. Topographical considerations in computerized peptide design
86. Topographical requirements for δ opioid ligands: The synthesis and biological properties of cyclic analogues of deltorphins and dermenkephalin
87. Amino acids with amphiphilic side chains: Deltorphin analogues with Phe3 replaced by all β-hydroxyphenylalanine diastereoisomers
88. Biological properties of a new fluorescent biphalin fragment analogue
89. Synthesis and biological properties of β-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased χ1 of Phe3 residues on peptide recognition for δ-opioid receptors
90. Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptides
91. Ferrocene-modified oligopeptide as model compound for charge-transfer interactions with organic electron acceptors
92. Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds. IF 3.794
93. Antiproliferative effects of [D-Pro2, D-Trp7,9]-Substance P and aprepitant on several cancer cell lines and their selectivity in comparison to normal cells.
94. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1
95. Inhibitors of the Neuropilin-1 and Vascular Endothelial Growth Factor 165 Interaction
96. Hybrid peptidomimetics for the use in neuropathicpain
97. Designing a Minimal Synthetase
98. Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin
99. Opioid-substance P chimeric peptides
100. Certain Aspects of Silver and Silver Nanoparticles in Wound Care: A Minireview
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.